Health & Wellness

CBD for Pets: A Natural Way to Support Your Furry Friend’s Well-Being

mm
Add MyCannabis.com to your preferred sources on Google

CBD is being studied for several conditions in dogs, but it is not a proven general wellness treatment for every pet. Evidence from a small canine trial cannot establish effectiveness in cats, horses, birds, or reptiles. Before buying a product, identify the problem with a veterinarian and discuss treatments supported for that species and condition.

What Is CBD?

Cannabidiol is one of the compounds found in cannabis and hemp. It does not cause the characteristic THC high. That distinction does not make CBD risk-free, nor does the presence of an endocannabinoid system prove that supplementing it will improve an animal’s health.

The FDA has not approved cannabis for any use in animals and cannot assure the safety or effectiveness of products marketed for them. A pet-specific label or a claim that a product is natural does not change that status.

What Does the Veterinary Evidence Show?

Cornell’s veterinary overview discusses studies of canine pain, stress, seizures, and itching. Some results are encouraging, but the studies use particular formulations, doses, and patient groups. Their findings should not become a promise that any CBD chew will treat the same condition.

Pain and Mobility

Research in dogs with osteoarthritis suggests possible benefit, but response varies and the evidence base is still developing. Difficulty rising, limping, or reduced activity needs diagnosis. Do not discontinue prescribed pain treatment because a testimonial or a small study reports that another dog improved.

Anxiety and Stress

Studies of responses to particular stressful events do not establish CBD as a treatment for every anxiety disorder. Separation distress, noise sensitivity, and a change in behavior may require different approaches. Discuss behavior management and established treatment options alongside any interest in CBD.

Seizures and Skin Problems

Canine seizure studies have generally evaluated CBD as an addition to existing treatment. They do not justify replacing antiseizure medication. Likewise, preliminary findings on itching do not show that CBD cures allergies or the underlying cause of a skin condition. Keep seizure logs and describe changes in scratching or behavior to the veterinarian.

Safety and Product Quality

CBD products can cause adverse effects, and cannabinoids can interact with medicines. Sedation, digestive changes, and laboratory abnormalities deserve attention. Veterinary review is particularly important when an animal already takes medication or has liver disease.

Do not give an animal human cannabis edibles. Ingredients and THC exposure can create additional hazards. The FDA lists lethargy, vomiting, drooling, agitation, tremors, and convulsions among possible adverse signs after cannabis exposure. Contact a veterinarian, animal emergency hospital, or animal poison-control service promptly if exposure or poisoning is suspected.

What to Ask Before Considering a Product

  • What diagnosis are we treating, and what established options are available?
  • Is there relevant evidence for this animal’s species and condition?
  • Could the proposed product interact with current medicines?
  • What changes would count as a meaningful benefit, and when should we stop?
  • Does a recent, batch-matched laboratory report identify cannabinoid content and the contaminants tested?

A laboratory report provides information about a tested sample. It does not prove clinical benefit or guarantee that every bottle is identical. Avoid treating a brand’s marketing language as evidence of treatment success.

Final Thoughts

CBD deserves careful veterinary research, but a broad promise of a happier, healthier pet goes beyond the evidence. Start with a diagnosis, retain effective care, and make any treatment decision around the individual animal’s needs and monitored response.

Sarah Schwefel is a journalist, research analyst, speaker, and patient advocate. After relocating for access to cannabis for her own health, she became engulphed in the cannabis and hemp industry determined to better help herself and other patients. In 2020, she became certified in endocannabinoid medicine studies from the American Journal of Endocannabinoid Medicine. Sarah uses her expertise to educate and advocate through her writing on various topics including legislation and the benefits plant medicine offers.